Form 4 for KURA Kura Oncology, Inc.
Accepted 2024-01-31 00:00:00 ET · period of report 2024-01-29 · accession 0000950170-24-009496 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-01-31 | 2024-01-29 | KURA | DOYLE THOMAS JAMES | SVP, Fin, Accounting | S - Sale | $17.80 | -2,318 | 48.1K | -5% | -$41.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-29 | S | D | 761 | $17.80 | 49,056 | D | — | — | (F2) Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 2/7/22. |
| 2 | Common | Common Stock | 2024-01-29 | S | D | 594 | $17.80 | 49,817 | D | — | — | (F1) Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/22. |
| 3 | Common | Common Stock | 2024-01-29 | S | D | 963 | $17.80 | 48,093 | D | — | — | (F3) Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 2/16/23. |